Public trial registry of the CCC-Munich

Trial AbbVie M12-914 (brocade-3)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AbbVie M12-914 (brocade-3)
World
Full title
:

A Phase III Randomized, Placebo-Controlled Trial of Carboplatin and Paclitaxel with or without the PARP Inhibitor Veliparib (ABT-888) in Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer

World
Responsible organization
:
Frauenklinik Frauenklinik Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C50.9 Brustdrüse, nicht näher bezeichnet
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Zielgerichtet - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Marion Kiechle Keine Organisationseinheit angegeben Magnifier